A-22
NDC 58264-0314, ASPERGILLUS FLAVUS, ASPERGILLUS FUMIGATUS, EUROTIUM HERBARIORUM, ASPERGILLUS NIDULANS, ASPERGILLUS NIGER VAR. NIGER, PENICILLIUM CAMEMBERTI, PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM, PENICILLIUM DIGITATUM, and PENICILLIUM ROQUEFORTI, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0314
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0314 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ASPERGILLUS FLAVUS30 [hp_X]/mL
- ASPERGILLUS FUMIGATUS30 [hp_X]/mL
- EUROTIUM HERBARIORUM30 [hp_X]/mL
- ASPERGILLUS NIDULANS30 [hp_X]/mL
- ASPERGILLUS NIGER VAR. NIGER30 [hp_X]/mL
- PENICILLIUM CAMEMBERTI30 [hp_X]/mL
- PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM30 [hp_X]/mL
- PENICILLIUM DIGITATUM30 [hp_X]/mL
- PENICILLIUM ROQUEFORTI30 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0314-1 | 58264031401 | 29.57 mL in 1 BOTTLE, GLASS (58264-0314-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0314 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0314 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0314. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.